10-Q: Investcorp AI Faces Delisting, Extends SPAC Deadline
Quarterly Report
Investcorp AI Acquisition Corp. reports a net loss, significant redemptions, and a Nasdaq delisting, while extending its business combination deadline to May 2027.
Summary
- Reported a net loss of $511,758 for the three months ended June 30, 2025, a significant decline from net income of $1,681,247 for the same period in 2024.
- Net loss for the six months ended June 30, 2025, was $610,317, compared to net income of $2,015,776 in the prior year period.
- Investments held in the Trust Account decreased substantially to $473,146 as of June 30, 2025, from $17,518,993 at December 31, 2024, primarily due to shareholder redemptions.
- Total liabilities increased to $6,835,463 as of June 30, 2025, from $5,706,474 at December 31, 2024.
- The company extended its business combination deadline to May 12, 2027, following shareholder approval on May 12, 2025.
- In connection with the May 2025 extension vote, 1,449,359 Class A ordinary shares were redeemed for approximately $17,521,050.
- The company was delisted from Nasdaq, with trading suspended on May 6, 2025, and securities now trading on the OTC Markets.
- Working Capital Loan from the Sponsor increased to $2,836,172 as of June 30, 2025, from $1,790,000 at December 31, 2024.
- Convertible Promissory Note from the Sponsor increased to $1,650,000 as of June 30, 2025, from $1,450,000 at December 31, 2024.
Sentiment
Score: 2
Explanation: The company is in a highly precarious position, marked by significant financial losses, dwindling trust account assets due to massive redemptions, and a delisting from Nasdaq. While it secured an extension for its business combination, the going concern warning and internal control weakness highlight severe operational and financial challenges, making a successful outcome highly uncertain.
Positives
- Successfully extended the business combination period to May 12, 2027, providing more time to identify and complete an acquisition.
- Secured additional working capital loans and convertible promissory notes from the Sponsor, totaling $2,836,172 and $1,650,000 respectively, to support operations and extension contributions.
Negatives
- Shifted from net income to significant net losses: $511,758 loss for Q2 2025 vs. $1,681,247 income for Q2 2024, and $610,317 loss for H1 2025 vs. $2,015,776 income for H1 2024.
- Substantial decrease in investments held in the Trust Account from $17,518,993 to $473,146 due to high shareholder redemptions.
- Delisted from Nasdaq and now trades on the OTC Markets, which may result in a very limited and adversely affected trading market.
- Accumulated deficit increased to $5,760,043 as of June 30, 2025, from $4,674,523 at December 31, 2024.
- Identified a material weakness in internal control over financial reporting related to ineffective review control for accrued expenses.
- Management has determined that the liquidity condition raises substantial doubt about the company's ability to continue as a going concern.
Risks
- Inability to successfully effect a Business Combination prior to May 12, 2027.
- Potential for the per share value of assets remaining for distribution to be less than the initial public offering price of $10.00 if a Business Combination is not completed.
- Sponsor's liability for third-party claims reducing Trust Account funds below a certain threshold, with no assurance the Sponsor has sufficient funds to satisfy these obligations.
- Potential exposure to the 1% excise tax on stock repurchases under the Inflation Reduction Act of 2022, particularly if a business combination with a U.S. target occurs.
- Increased market volatility and economic uncertainties due to global social and political circumstances, including tariff policies, trade tensions, and ongoing conflicts (Russia/Ukraine, Hamas/Israel), which may adversely affect the ability to consummate a Business Combination or the operations of a target business.
- Dependence on the ability to raise equity and debt financing, which may be impacted by global events, leading to increased market volatility or decreased market liquidity.
- The limited market and potential adverse effect on trading price due to delisting from Nasdaq and trading on the OTC Markets.
- Material weakness in internal control over financial reporting, which could adversely affect the ability to record, process, summarize, and report financial information.
Future Outlook
The company's primary future outlook is to complete a business combination by May 12, 2027, focusing its search on companies within the Indian market. It expects to use remaining cash in the trust account, proceeds from share sales, and debt financing for this purpose. The company acknowledges that its ability to continue as a going concern is in substantial doubt without a successful capital raise or business combination.
Management Comments
- "We intend to focus our search on companies within the Indian market."
- "We do not expect to generate any operating revenues until after the completion of our initial business combination."
- "Management has determined that the liquidity condition raises substantial doubt about the Company’s ability to continue as a going concern."
- "The Company, with the oversight of its Audit Committee, is actively undertaking remediation efforts to address the material weakness identified above and is developing measures and controls to prevent a re-occurrence of such a deficiency in the future."
Industry Context
As a Special Purpose Acquisition Company (SPAC), the company operates within a highly specific and time-constrained industry segment. The significant redemptions and subsequent delisting from Nasdaq reflect a broader trend of increased investor skepticism and redemptions in the SPAC market, particularly for those struggling to identify and close a suitable business combination within their initial deadlines. The shift to OTC Markets indicates a loss of mainstream investor visibility and liquidity, common for SPACs that fail to de-SPAC on major exchanges. The stated focus on the Indian market suggests a niche strategy, but the current financial state and delisting severely hamper its ability to attract a viable target or additional capital.
Comparison to Industry Standards
- The company's high redemption rates (over 97% of initial shares redeemed across multiple extension votes) are significantly worse than the average SPAC redemption rates, which have historically varied but rarely reached such extreme levels, indicating a strong lack of investor confidence in the company's ability to complete a desirable business combination.
- The delisting from Nasdaq due to failure to meet listing rules (MVLS and annual meeting) and the inability to complete a business combination within the initial 36-month timeframe (Rule IM-5101-2) places the company in a category of underperforming SPACs that fail to execute their core mandate, unlike successful SPACs that either complete a merger or liquidate within their initial or first extended periods.
- The reliance on sponsor loans for working capital and extension contributions, while common in SPACs, is exacerbated by the dwindling trust account, indicating a distressed financial position compared to SPACs with robust trust balances and less need for continuous sponsor funding.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Class B ordinary shares holder | Sponsor (ICE I Holdings Pte. Ltd.) holding 6,468,749 shares | Sponsor (ICE I Holdings Pte. Ltd.) holding 1 share (remaining shares converted to Class A) | 2024-08-12 | Sponsor elected to convert Class B ordinary shares into Class A ordinary shares on a one-to-one basis. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Amendment to Articles of Association | Extended the date to consummate a business combination from May 12, 2025, to May 12, 2027. | 2025-05-12 | Provides additional time for the company to identify and complete a business combination, but also reflects previous delays and high redemptions. |
| Internal Control Weakness | Identified a material weakness in internal control over financial reporting related to an ineffective review control to prevent or detect a material misstatement, specifically an over accrual of legal fees and an adjustment to accrued expenses. | 2025-06-30 | Indicates potential for financial misstatements and requires ongoing remediation efforts, posing a risk to financial reporting reliability. |
Related Party Transactions
- Working Capital Loan from Sponsor: $2,836,172 outstanding as of June 30, 2025. Non-interest bearing, convertible into Private Placement Warrants.
- Convertible Promissory Note from Sponsor: $1,650,000 outstanding as of June 30, 2025. Non-interest bearing, convertible into non-transferable, non-redeemable ordinary shares.
- Due to Sponsor: $161,324 outstanding as of June 30, 2025. Non-interest bearing, due on demand.
- Administrative Services Agreement: Monthly fee of $10,000 paid to the Sponsor for office space, utilities, and secretarial/administrative services.
- Founder Shares: Sponsor initially purchased 7,187,500 Class B shares for $25,000, later surrendered 718,750 shares, and converted 6,468,749 Class B shares to Class A shares.
Stakeholder Impact
- Shareholders: Significant dilution of trust account value due to high redemptions. Delisting from Nasdaq to OTC Markets will likely result in reduced liquidity and potentially lower share prices. The going concern warning indicates a high risk of total loss of investment if a business combination is not completed.
- Sponsor: Continues to provide significant financial support through loans and notes, indicating a strong commitment but also exposure to substantial risk if a business combination fails.
- Creditors: The company's ability to repay loans and other liabilities is contingent on completing a business combination or having sufficient funds outside the trust account, which is uncertain.
Next Steps
- Identify and consummate a Business Combination by May 12, 2027.
- File a registration statement with the SEC covering the issuance of Class A ordinary shares upon exercise of Public Warrants as soon as practicable after a Business Combination.
- Continue remediation efforts to address the material weakness in internal control over financial reporting.
Key Dates
| Date | Description |
|---|---|
| 2021-02-19 | Company incorporated in the Cayman Islands. |
| 2022-03-12 | Company issued 7,187,500 Class B ordinary shares to the Sponsor. |
| 2022-03-22 | Sponsor surrendered 718,750 Class B ordinary shares. |
| 2022-05-09 | Registration statement for Initial Public Offering declared effective. |
| 2022-05-12 | Initial Public Offering consummated; 22,500,000 units sold at $10.00/unit, plus 3,375,000 over-allotment units. Sale of 14,400,000 Private Placement Warrants at $1.00/warrant, plus 1,687,500 additional Private Placement Warrants. |
| 2023-08-09 | Sponsor agreed to loan up to $1,200,000 for Extension Contributions (2023 Notes). |
| 2023-08-11 | Shareholders approved extension of business combination deadline to August 12, 2024. 16,085,554 Class A shares redeemed for $172,774,717. |
| 2023-08-18 | Redemption payments made in connection with the August 2023 redemption. |
| 2023-12-08 | Company entered into a non-interest bearing convertible unsecured Working Capital Loan of up to $3,000,000 from the Sponsor. |
| 2024-08-12 | Shareholders approved extension of business combination deadline to May 12, 2025. 8,314,066 Class A shares redeemed for $95,447,584. Sponsor elected to convert 6,468,749 Class B shares into Class A ordinary shares. |
| 2024-11-04 | Received Nasdaq notification of non-compliance with minimum $50,000,000 market value of listed securities requirement. |
| 2024-11-18 | Procedures for Class B to Class A share conversion completed. |
| 2025-03-05 | Received Nasdaq notification of non-compliance for failing to hold an annual meeting. |
| 2025-04-24 | Filed definitive proxy statement to seek extension of business combination period to May 12, 2027. |
| 2025-04-29 | Received Nasdaq letter stating securities would be delisted. |
| 2025-05-06 | Trading of securities suspended on Nasdaq; began trading on OTC Markets. |
| 2025-05-12 | Shareholders approved extension of business combination deadline to May 12, 2027. 1,449,359 Class A shares redeemed for $17,521,050. |
| 2025-07-04 | President Trump signed the One Big Beautiful Bill Act (OBBBA). |
| 2025-07-14 | Nasdaq filed Form 25 with the SEC, removing the company's securities from listing and registration. |
| 2025-08-14 | Date of filing of this 10-Q report. |
| 2027-05-12 | New deadline for the company to complete its Initial Business Combination. |
Recommendation
strong sellThe company faces severe challenges, including substantial net losses, a drastically depleted trust account due to high redemptions, and a delisting from Nasdaq to the less liquid OTC Markets. Management has expressed substantial doubt about its ability to continue as a going concern. While an extension for a business combination has been secured, the fundamental issues of capital depletion and lack of a target, coupled with internal control weaknesses, present an extremely high-risk profile. The likelihood of a successful business combination that creates shareholder value appears very low, making the stock a strong sell.
Keywords
SPAC, blank check company, business combination, redemption, Nasdaq delisting, OTC Markets, warrants, financial reporting, going concern, India market, acquisition, Investcorp AI
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.